Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research.
Multiple sclerosis guideline production takes off.
Dynamics and Mechanisms of CNS Myelination.
Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis.
High variability of fabry disease manifestations in an extended italian family.
Injury to white matter tracts in relapsing-remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics.
Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.
Serum exosomes in pregnancy-associated immune modulation and neuroprotection during CNS autoimmunity.
Transitions between SNF and home-based care in patients with multiple sclerosis.
Role of prolactin in B cell regulation in multiple sclerosis.
The case for measuring anti-drug antibodies in people with multiple sclerosis.
Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13.
Endometriosis and susceptibility to multiple sclerosis: is there any absolute truth?
Relevance of CD34+ Cells as a Reservoir for JC Virus in Patients With Multiple Sclerosis-Reply.
18F-DOPA, a Clinically Available PET Tracer to Study Brain Inflammation?
Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network.
Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice.
I-BET151 selectively regulates IL-6 production.
Analytical performances of SPAPLUS® turbidimeter for the quantification of albumin and IgG in serum and cerebrospinal fluid.
The Incidence and Prevalence of Thyroid Disease Do Not Differ in the Multiple Sclerosis and General Populations: A Validation Study Using Administrative Data.
Novel cerebrospinal fluid and serum autoantibody targets for Clinically Isolated Syndrome.
The antibody genetics of multiple sclerosis: comparing next-generation sequencing to sanger sequencing.
Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria.
Automatic Counting of Microglial Cells in Healthy and Glaucomatous Mouse Retinas.
Therapeutic Decisions in Multiple Sclerosis: Moving Beyond Efficacy.
Pages
« first
‹ previous
…
502
503
504
505
506
507
508
509
510
…
next ›
last »